Clinical Trial Update: DPP4inhibitors in Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on DPP4 inhibitors for Type 1 Diabetes and hypoglycemia outcomes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycaemia
• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Dundee | Conditions: Type 1 Diabetes, Hypoglycaemia | Phase 3 | Status: COMPLETED